In summary (Figure 7), we demonstrated that the elevated lncRNA TRERNA1 levels promoted HCC cell metastasis in vitro and in vivo; the aberrant expression of TRERNA1 relates to metastatic HCC and a poor prognosis for patients. Here, TRERNA1 is linked to hepatocellular carcinoma.